Do different brands of oral contraceptives differ in their effects on cardiovascular disease?
Crook
D
D
Wynn Division of Metabolic Medicine, National Heart & Lung Institute, Imperial College School of Medicine, London.
D002318:Cardiovascular Diseases / Q000139:chemically induced*; D003257:Consumer Product Safety; D003276:Contraceptives, Oral / Q000009:adverse effects*; D005062:European Union; D005260:Female; D006801:Humans; D045167:Progesterone Congeners / Q000009:adverse effects*; D006113:United Kingdom
D003276:Contraceptives, Oral; D045167:Progesterone Congeners